| Q35636989 | A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease |
| Q38840236 | Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis. |
| Q63214358 | Autologe Stammzelltransplantation bei systemischer Sklerose |
| Q63214396 | Autologous hematopoietic stem cell transplantation for autoimmune diseases |
| Q37810087 | Autologous hematopoietic stem cell transplantation in autoimmune diseases |
| Q42610157 | Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial |
| Q53538901 | Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. |
| Q37311078 | Autologous stem cell transplantation for systemic sclerosis |
| Q35554404 | Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry |
| Q50875933 | Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. |
| Q35934224 | Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis |
| Q33763415 | Corticosteroids and the risk of scleroderma renal crisis: a systematic review |
| Q40237552 | Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? |
| Q34583730 | Gastrointestinal manifestations of systemic sclerosis |
| Q36020897 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation |
| Q35870515 | Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective |
| Q38466458 | Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis |
| Q35547252 | Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders |
| Q34017756 | Hematopoietic cell transplantation for Crohn's disease; is it time? |
| Q35925071 | High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study |
| Q56893060 | Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients |
| Q36067732 | Immunomodulatory therapy for SSc: will high-intensity immunosuppression with stem cell rescue improve outcome? |
| Q40903255 | Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease. |
| Q35169069 | Interstitial lung disease in scleroderma |
| Q37593784 | Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients. |
| Q35953258 | Non-myeloablative stem cell transplantation for autoimmune diseases |
| Q37365318 | Recent advances in the treatment of systemic sclerosis |
| Q50772839 | Red cell fragmentation preceding a renal crisis in a patient with systemic sclerosis undergoing haematopoietic stem cell transplantation. |
| Q34372648 | Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial |
| Q38287103 | Stem cell autograft and allograft in autoimmune diseases |
| Q24187598 | Stem cell transplantation for systemic sclerosis |
| Q36309579 | Stem cell transplantation in autoimmune diseases: an update |
| Q34552765 | Stem cells in clinical practice: applications and warnings |
| Q80552104 | The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis |
| Q34500124 | The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders |
| Q37194001 | Treatment of systemic sclerosis: potential role for stem cell transplantation. |
| Q38091659 | Update on stem cell transplantation for systemic sclerosis: recent trial results |
| Q53310931 | Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). |
| Q84600110 | [Hematopoietic stem cell transplantation in systemic autoimmune diseases. State of the art] |
| Q75310699 | [Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis] |
| Q81591700 | [Therapeutic intensification and autologous stem cell transplantation in autoimmune diseases] |
| Q79836579 | [Treatment of systemic sclerosis] |
Search more.